Serbia - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Serbia Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases was down by 22.2% year on year. With 4 Cases in 2019, the country was number 280 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. India ranked the highest with 66,255 Cases in 2019, that is a growth of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
Date | Units (Cases) |
---|---|
2019 | 4.00 |
2018 | 5.00 |
2017 | 5.00 |
2016 | 8.00 |
2015 | 5.00 |
Download all data from 2005 to 2019
How does Serbia rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
# | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
280 |
#280
Greece
|
4 | 2014 | -79.0 % | -21.0 % | View data | |
280 |
#280
Serbia
|
4 | 2019 | -20.0 % | -22.2 % | View data | |
280 |
#280
Uruguay
|
4 | 2019 | +0.0 % | +14.9 % | View data |